A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.
On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...
People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...